We’re bringing together medical physics, nuclear medicine and radiotherapy in new ways to shift the paradigm of cancer care. Our belief in the difference we can make knows no bounds. To create a machine that combines biotargeting with radiation and enable the first-ever systemic reach for radiotherapy for patients with any stage of cancer.
Find locations served, office locations
- Business Type:
- Industry Type:
- Medical Equipment
- Market Focus:
- Globally (various continents)
- Year Founded:
With a bold mission and the drive to build a high-performing business, RefleXion captured the interest of blue-chip investors, all committed to advancing a new modality in cancer care, especially for stage-four cancer patients.
To date, RefleXion has raised nearly $300M from premier investment firms including PSP Investments, TPG Growth / The Rise Fund, KCK Group, Sofinnova Partners, Venrock, T. Rowe Price, and global pharmaceutical leaders, Pfizer Ventures, Johnson & Johnson Innovation, and Oxford Capital.
The National Cancer Institute (NCI) also provided grant funding through its Small Business Innovation Research (SBIR) Program.
To reveal cancer as never before and beat it for everyone, everywhere.